IGM Biosciences, Inc. Operating Lease Right-of-Use Assets
IGM Biosciences, Inc. had Operating Lease Right-of-Use Assets of $0 as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-07-31
- 2025-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2025-03-31: Operating Lease, Right-of-Use Asset $28.80M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $38.52M.
- 2024-09-30: Operating Lease, Right-of-Use Asset $39.09M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $28.80M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $38.52M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $39.09M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $33.04M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $34.47M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $35.77M 10-K · filed 2025-03-06 |
| 2023-09-30 | $37.09M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $38.41M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $39.10M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $39.59M 10-K · filed 2024-03-07 |
| 2022-09-30 | $26.96M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $28.07M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $28.94M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $27.85M 10-K · filed 2023-03-30 |
| 2021-09-30 | $28.56M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $11.92M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $12.76M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $11.59M 10-K · filed 2022-03-29 |
| 2020-09-30 | $12.23M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $12.87M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $13.51M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $14.14M 10-K · filed 2021-03-30 |
| 2019-09-30 | $9.88M 10-Q · filed 2019-11-07 |
| 2019-01-01 | $600.00K 10-K · filed 2020-03-26 |